RETIA MEDICAL AIMS TO ADVANCE THE USE OF CARDIAC OUTPUT (CO) MONITORING TO IMPROVE PATIENT CARE BY PROVIDING MEMBERS OF THE CRITICAL CARE TEAM WITH A MORE ACCURATE, EASY-TO-USE, AND AFFORDABLE HEMODYNAMIC MONITOR THAT SUPPORTS CONFIDENT, DATA-BASED DECISIONS.
Retia brings together industry-leading expertise in physiology, signal processing and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to giving more clinicians access to CO monitoring by reducing the cost and inconvenience that limit the use of traditional CO technologies to the most high-risk patients.
Retias highly accurate, easy-to-use and cost-effective lead product, the Argos Cardiac Output Monitor equipped with the companys proprietary Multi-Beat Analysis (MBA™) algorithm, guarantees superior CO monitoring performance, quality, reliability, and compatibility for enhanced hemodynamic management. Retia is also developing new algorithms to aid in detecting, diagnosing and treating shock. These include algorithms for calculating ejection fraction and end diastolic volume from arterial lines; predicting and detecting hypotension via non-invasive blood pressure; and calculating continuous CO and left atrial pressure from pulmonary artery pressure waveforms.